Elizabeth Austen Lawson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oxytocin | 36 | 2024 | 402 | 13.150 |
Why?
|
Anorexia Nervosa | 50 | 2024 | 1363 | 7.530 |
Why?
|
Appetite | 12 | 2024 | 247 | 3.930 |
Why?
|
Eating | 17 | 2024 | 1538 | 2.920 |
Why?
|
Ghrelin | 10 | 2024 | 251 | 2.180 |
Why?
|
Peptide YY | 6 | 2024 | 135 | 2.160 |
Why?
|
Postprandial Period | 6 | 2024 | 319 | 1.630 |
Why?
|
Fasting | 9 | 2024 | 1608 | 1.610 |
Why?
|
Bone Density | 20 | 2023 | 3561 | 1.490 |
Why?
|
Administration, Intranasal | 8 | 2024 | 485 | 1.460 |
Why?
|
Hypopituitarism | 4 | 2020 | 251 | 1.450 |
Why?
|
Appetite Regulation | 2 | 2021 | 84 | 1.390 |
Why?
|
Thinness | 7 | 2024 | 483 | 1.330 |
Why?
|
Amenorrhea | 9 | 2017 | 484 | 1.330 |
Why?
|
Obesity | 21 | 2024 | 13065 | 1.300 |
Why?
|
Feeding Behavior | 12 | 2023 | 3202 | 1.190 |
Why?
|
Overweight | 9 | 2021 | 2428 | 1.170 |
Why?
|
Body Weight | 17 | 2023 | 4630 | 1.170 |
Why?
|
Body Composition | 8 | 2024 | 2455 | 1.080 |
Why?
|
Motivation | 7 | 2024 | 2034 | 0.920 |
Why?
|
Cholecystokinin | 2 | 2022 | 115 | 0.910 |
Why?
|
Leptin | 9 | 2023 | 1598 | 0.890 |
Why?
|
Energy Metabolism | 6 | 2024 | 2901 | 0.770 |
Why?
|
Hydrocortisone | 6 | 2015 | 1836 | 0.760 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2019 | 705 | 0.760 |
Why?
|
Endocrine System Diseases | 2 | 2022 | 250 | 0.750 |
Why?
|
Food | 3 | 2023 | 770 | 0.740 |
Why?
|
Psychopathology | 6 | 2023 | 435 | 0.710 |
Why?
|
Cross-Sectional Studies | 34 | 2023 | 26348 | 0.710 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2020 | 20 | 0.700 |
Why?
|
Appetitive Behavior | 1 | 2019 | 39 | 0.680 |
Why?
|
Pituitary-Adrenal System | 3 | 2015 | 557 | 0.680 |
Why?
|
Comorbidity | 7 | 2024 | 10601 | 0.680 |
Why?
|
Young Adult | 53 | 2024 | 60038 | 0.660 |
Why?
|
Hip | 3 | 2017 | 255 | 0.660 |
Why?
|
Diabetes Insipidus | 1 | 2019 | 144 | 0.630 |
Why?
|
Body Dysmorphic Disorders | 2 | 2019 | 243 | 0.630 |
Why?
|
Vasopressins | 1 | 2020 | 353 | 0.620 |
Why?
|
Menstruation | 3 | 2019 | 310 | 0.610 |
Why?
|
Energy Intake | 5 | 2024 | 2141 | 0.600 |
Why?
|
Affective Symptoms | 2 | 2017 | 418 | 0.590 |
Why?
|
Pelvic Bones | 1 | 2020 | 270 | 0.580 |
Why?
|
Weight Loss | 4 | 2024 | 2710 | 0.560 |
Why?
|
Adolescent | 50 | 2024 | 89163 | 0.550 |
Why?
|
Hypothalamus | 5 | 2022 | 1004 | 0.540 |
Why?
|
Visual Perception | 3 | 2021 | 1406 | 0.540 |
Why?
|
Anorexia | 2 | 2014 | 152 | 0.530 |
Why?
|
Body Mass Index | 16 | 2024 | 13030 | 0.530 |
Why?
|
Diet, Sodium-Restricted | 1 | 2018 | 291 | 0.530 |
Why?
|
Receptors, Oxytocin | 1 | 2016 | 71 | 0.530 |
Why?
|
Spine | 5 | 2017 | 1142 | 0.530 |
Why?
|
Metabolism | 1 | 2017 | 193 | 0.530 |
Why?
|
Angiotensin II | 1 | 2018 | 849 | 0.490 |
Why?
|
Adult | 72 | 2024 | 223528 | 0.490 |
Why?
|
Female | 87 | 2024 | 396926 | 0.490 |
Why?
|
Appetite Depressants | 1 | 2015 | 108 | 0.470 |
Why?
|
Sodium, Dietary | 1 | 2018 | 427 | 0.470 |
Why?
|
Satiation | 3 | 2022 | 84 | 0.460 |
Why?
|
Hormones | 2 | 2009 | 870 | 0.460 |
Why?
|
Object Attachment | 1 | 2017 | 333 | 0.460 |
Why?
|
Maternal Behavior | 1 | 2016 | 309 | 0.460 |
Why?
|
Psychotropic Drugs | 2 | 2017 | 888 | 0.460 |
Why?
|
Humans | 115 | 2024 | 768369 | 0.450 |
Why?
|
Subcutaneous Fat | 1 | 2017 | 402 | 0.450 |
Why?
|
Anxiety | 7 | 2023 | 4655 | 0.440 |
Why?
|
Hunger | 4 | 2021 | 207 | 0.430 |
Why?
|
Binge-Eating Disorder | 3 | 2022 | 156 | 0.420 |
Why?
|
Neuropeptides | 1 | 2018 | 950 | 0.410 |
Why?
|
Bone and Bones | 3 | 2014 | 2589 | 0.410 |
Why?
|
Intra-Abdominal Fat | 1 | 2017 | 623 | 0.390 |
Why?
|
Executive Function | 2 | 2017 | 1402 | 0.390 |
Why?
|
Bone Diseases, Metabolic | 2 | 2012 | 411 | 0.390 |
Why?
|
Hypothalamic Diseases | 2 | 2009 | 134 | 0.370 |
Why?
|
Double-Blind Method | 9 | 2024 | 12450 | 0.340 |
Why?
|
Cross-Over Studies | 5 | 2020 | 2103 | 0.340 |
Why?
|
Reward | 4 | 2023 | 987 | 0.330 |
Why?
|
Hemangiopericytoma | 1 | 2009 | 71 | 0.320 |
Why?
|
Homeostasis | 1 | 2019 | 3351 | 0.310 |
Why?
|
Brain | 7 | 2024 | 27439 | 0.310 |
Why?
|
Blood Glucose | 3 | 2019 | 6429 | 0.290 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2009 | 268 | 0.290 |
Why?
|
Genomic Imprinting | 1 | 2009 | 324 | 0.280 |
Why?
|
Social Support | 1 | 2017 | 2195 | 0.280 |
Why?
|
Sodium | 1 | 2012 | 1595 | 0.280 |
Why?
|
Weight Gain | 7 | 2023 | 2357 | 0.280 |
Why?
|
Male | 37 | 2024 | 364761 | 0.280 |
Why?
|
Athletes | 4 | 2017 | 1162 | 0.280 |
Why?
|
Adipose Tissue | 5 | 2024 | 3335 | 0.270 |
Why?
|
Depression | 6 | 2019 | 8235 | 0.270 |
Why?
|
Child | 22 | 2024 | 80856 | 0.260 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4247 | 0.260 |
Why?
|
Amygdala | 5 | 2023 | 1382 | 0.260 |
Why?
|
Carotid Artery, Internal | 1 | 2008 | 446 | 0.260 |
Why?
|
Bone Diseases | 1 | 2009 | 418 | 0.260 |
Why?
|
Case-Control Studies | 10 | 2022 | 22286 | 0.250 |
Why?
|
Arteriovenous Fistula | 1 | 2008 | 321 | 0.250 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2007 | 361 | 0.250 |
Why?
|
Depressive Disorder | 3 | 2016 | 3738 | 0.250 |
Why?
|
Osteoporosis | 2 | 2012 | 1606 | 0.240 |
Why?
|
Human Growth Hormone | 4 | 2017 | 648 | 0.230 |
Why?
|
Calorimetry, Indirect | 2 | 2015 | 176 | 0.230 |
Why?
|
Severity of Illness Index | 6 | 2019 | 15965 | 0.220 |
Why?
|
Cerebral Cortex | 4 | 2014 | 5827 | 0.220 |
Why?
|
Testosterone | 6 | 2019 | 2493 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36840 | 0.220 |
Why?
|
Absorptiometry, Photon | 8 | 2017 | 1749 | 0.210 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2015 | 1943 | 0.210 |
Why?
|
Social Perception | 2 | 2019 | 434 | 0.210 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2021 | 1994 | 0.210 |
Why?
|
Pica | 2 | 2022 | 37 | 0.200 |
Why?
|
Dyspepsia | 1 | 2023 | 116 | 0.200 |
Why?
|
Radius | 2 | 2017 | 443 | 0.200 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15638 | 0.200 |
Why?
|
Hypoglycemia | 1 | 2009 | 894 | 0.190 |
Why?
|
Prader-Willi Syndrome | 1 | 2022 | 79 | 0.190 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2585 | 0.190 |
Why?
|
Middle Aged | 26 | 2024 | 223406 | 0.190 |
Why?
|
Adiposity | 2 | 2024 | 1888 | 0.180 |
Why?
|
Trust | 2 | 2018 | 532 | 0.180 |
Why?
|
Retrospective Studies | 13 | 2023 | 81835 | 0.180 |
Why?
|
Fibronectins | 2 | 2014 | 725 | 0.180 |
Why?
|
Brain Mapping | 4 | 2024 | 6740 | 0.170 |
Why?
|
Bulimia | 1 | 2022 | 405 | 0.170 |
Why?
|
Arginine Vasopressin | 1 | 2019 | 126 | 0.160 |
Why?
|
Craniopharyngioma | 1 | 2022 | 279 | 0.160 |
Why?
|
Diet, Protein-Restricted | 1 | 2019 | 73 | 0.160 |
Why?
|
Pituitary Gland | 1 | 2021 | 634 | 0.150 |
Why?
|
Feeding and Eating Disorders of Childhood | 1 | 2018 | 42 | 0.150 |
Why?
|
Bone Resorption | 2 | 2013 | 727 | 0.150 |
Why?
|
Androstane-3,17-diol | 1 | 2017 | 20 | 0.150 |
Why?
|
Impulsive Behavior | 1 | 2020 | 350 | 0.150 |
Why?
|
Hyperprolactinemia | 2 | 2009 | 124 | 0.150 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5803 | 0.150 |
Why?
|
Reference Values | 4 | 2019 | 4941 | 0.140 |
Why?
|
Cognition | 4 | 2023 | 7062 | 0.140 |
Why?
|
Vegetables | 2 | 2021 | 1202 | 0.140 |
Why?
|
Oligomenorrhea | 1 | 2017 | 42 | 0.140 |
Why?
|
Treatment Outcome | 7 | 2024 | 65408 | 0.140 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2019 | 6035 | 0.140 |
Why?
|
Fast Foods | 1 | 2019 | 216 | 0.140 |
Why?
|
Pregnanolone | 1 | 2017 | 67 | 0.140 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2009 | 241 | 0.140 |
Why?
|
Adolescent Development | 1 | 2020 | 283 | 0.140 |
Why?
|
Bulimia Nervosa | 1 | 2018 | 207 | 0.130 |
Why?
|
Nutritive Value | 1 | 2019 | 349 | 0.130 |
Why?
|
Lipolysis | 1 | 2017 | 211 | 0.130 |
Why?
|
Verbal Learning | 2 | 2017 | 465 | 0.130 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3854 | 0.130 |
Why?
|
Exercise | 1 | 2013 | 5940 | 0.130 |
Why?
|
Radioimmunoassay | 3 | 2010 | 862 | 0.130 |
Why?
|
Social Behavior | 3 | 2019 | 1144 | 0.130 |
Why?
|
Cues | 1 | 2021 | 884 | 0.130 |
Why?
|
Mental Recall | 2 | 2017 | 1226 | 0.130 |
Why?
|
Reaction Time | 2 | 2020 | 2102 | 0.120 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2019 | 607 | 0.120 |
Why?
|
Facial Expression | 1 | 2019 | 515 | 0.120 |
Why?
|
Pituitary Neoplasms | 2 | 2022 | 1325 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18047 | 0.120 |
Why?
|
Acromegaly | 1 | 2017 | 316 | 0.120 |
Why?
|
Dietary Proteins | 1 | 2019 | 960 | 0.110 |
Why?
|
Interpersonal Relations | 3 | 2018 | 1439 | 0.110 |
Why?
|
Weight-Bearing | 2 | 2015 | 533 | 0.110 |
Why?
|
Attitude | 1 | 2018 | 773 | 0.110 |
Why?
|
Child Behavior | 1 | 2019 | 862 | 0.110 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6527 | 0.110 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2013 | 115 | 0.100 |
Why?
|
Hypothalamic Hormones | 1 | 2013 | 145 | 0.100 |
Why?
|
Pituitary Hormones | 1 | 2013 | 182 | 0.100 |
Why?
|
Animals | 7 | 2022 | 169424 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2021 | 712 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1193 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2023 | 1309 | 0.100 |
Why?
|
Judgment | 1 | 2014 | 273 | 0.100 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2013 | 619 | 0.100 |
Why?
|
Mechanical Phenomena | 1 | 2013 | 143 | 0.100 |
Why?
|
Androgens | 2 | 2011 | 1285 | 0.100 |
Why?
|
Etidronic Acid | 1 | 2011 | 63 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2232 | 0.090 |
Why?
|
Fibroblast Growth Factors | 2 | 2014 | 873 | 0.090 |
Why?
|
Sex Characteristics | 2 | 2014 | 2667 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1192 | 0.090 |
Why?
|
Finite Element Analysis | 1 | 2013 | 441 | 0.090 |
Why?
|
Food Preferences | 1 | 2014 | 399 | 0.090 |
Why?
|
Estrogen Replacement Therapy | 1 | 2017 | 1209 | 0.090 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2015 | 600 | 0.090 |
Why?
|
Hyponatremia | 1 | 2012 | 281 | 0.090 |
Why?
|
Administration, Cutaneous | 3 | 2019 | 716 | 0.090 |
Why?
|
Phobic Disorders | 1 | 2012 | 441 | 0.080 |
Why?
|
Dietary Fats | 1 | 2017 | 2003 | 0.080 |
Why?
|
Social Marketing | 1 | 2009 | 52 | 0.080 |
Why?
|
Skin Neoplasms | 1 | 2009 | 5891 | 0.080 |
Why?
|
Suicidal Ideation | 1 | 2019 | 1466 | 0.080 |
Why?
|
Ergolines | 1 | 2009 | 57 | 0.080 |
Why?
|
Pituitary Function Tests | 1 | 2008 | 24 | 0.080 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 756 | 0.080 |
Why?
|
Contraceptives, Oral | 2 | 2009 | 562 | 0.080 |
Why?
|
Hip Fractures | 3 | 2014 | 996 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2719 | 0.080 |
Why?
|
Anthropometry | 1 | 2013 | 1343 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2015 | 712 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1568 | 0.080 |
Why?
|
Age Factors | 3 | 2019 | 18477 | 0.070 |
Why?
|
Dehydroepiandrosterone | 1 | 2009 | 259 | 0.070 |
Why?
|
Pilot Projects | 2 | 2018 | 8730 | 0.070 |
Why?
|
Heart Valves | 1 | 2009 | 284 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2737 | 0.070 |
Why?
|
Tibia | 1 | 2013 | 1075 | 0.070 |
Why?
|
Adrenal Insufficiency | 1 | 2008 | 194 | 0.070 |
Why?
|
Hyperthyroidism | 1 | 2008 | 295 | 0.070 |
Why?
|
Restaurants | 1 | 2009 | 232 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3237 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2362 | 0.070 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.060 |
Why?
|
Thyroid Hormones | 1 | 2008 | 407 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4269 | 0.060 |
Why?
|
Body Image | 1 | 2010 | 644 | 0.060 |
Why?
|
Glucose | 1 | 2017 | 4355 | 0.060 |
Why?
|
RNA, Untranslated | 1 | 2009 | 458 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2010 | 6242 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2754 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14766 | 0.060 |
Why?
|
Insulin | 3 | 2015 | 6606 | 0.060 |
Why?
|
Area Under Curve | 1 | 2009 | 1640 | 0.060 |
Why?
|
Amyloid | 1 | 2009 | 852 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1891 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10863 | 0.060 |
Why?
|
Lipoproteins, LDL | 1 | 2007 | 644 | 0.060 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 797 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2017 | 3974 | 0.050 |
Why?
|
Health Promotion | 2 | 2021 | 2215 | 0.050 |
Why?
|
Angiography | 1 | 2008 | 1597 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2015 | 2063 | 0.050 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 682 | 0.050 |
Why?
|
Phonetics | 1 | 1984 | 204 | 0.050 |
Why?
|
Diet | 2 | 2018 | 8098 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 13045 | 0.050 |
Why?
|
Neural Pathways | 3 | 2019 | 3122 | 0.050 |
Why?
|
Quality of Life | 2 | 2023 | 13497 | 0.050 |
Why?
|
Fetus | 1 | 2009 | 1883 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54913 | 0.050 |
Why?
|
Saline Solution, Hypertonic | 1 | 2021 | 114 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2023 | 5308 | 0.050 |
Why?
|
Time Factors | 3 | 2018 | 40271 | 0.040 |
Why?
|
Treatment Failure | 2 | 2019 | 2655 | 0.040 |
Why?
|
Up-Regulation | 1 | 2009 | 4132 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6879 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2705 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2021 | 219 | 0.040 |
Why?
|
Tryptophan | 1 | 2021 | 483 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9505 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2008 | 2170 | 0.040 |
Why?
|
Speech Perception | 1 | 1984 | 512 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23639 | 0.040 |
Why?
|
Ventral Tegmental Area | 1 | 2019 | 136 | 0.040 |
Why?
|
Appetite Stimulants | 1 | 2018 | 14 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4931 | 0.040 |
Why?
|
Gastrectomy | 1 | 2023 | 696 | 0.040 |
Why?
|
Immunity | 1 | 2024 | 1002 | 0.040 |
Why?
|
Risk Factors | 4 | 2019 | 74915 | 0.040 |
Why?
|
Arginine | 1 | 2021 | 923 | 0.040 |
Why?
|
Health Behavior | 1 | 2009 | 2649 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2007 | 3234 | 0.030 |
Why?
|
Mass Screening | 1 | 2012 | 5455 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1364 | 0.030 |
Why?
|
Gastric Emptying | 1 | 2018 | 246 | 0.030 |
Why?
|
Fruit | 1 | 2021 | 1165 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2359 | 0.030 |
Why?
|
Femur | 2 | 2014 | 1311 | 0.030 |
Why?
|
Acylation | 1 | 2014 | 98 | 0.030 |
Why?
|
Estradiol | 2 | 2012 | 1948 | 0.030 |
Why?
|
Memory | 1 | 1984 | 2210 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15879 | 0.030 |
Why?
|
Progesterone | 1 | 2017 | 749 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1834 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6320 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8636 | 0.030 |
Why?
|
Self Administration | 1 | 2014 | 387 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2017 | 7133 | 0.030 |
Why?
|
Risk Assessment | 3 | 2019 | 24310 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39429 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4861 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8201 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2018 | 2733 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20763 | 0.020 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2009 | 41 | 0.020 |
Why?
|
Osteoarthritis | 1 | 1978 | 1070 | 0.020 |
Why?
|
Fear | 1 | 2018 | 1494 | 0.020 |
Why?
|
Outpatients | 1 | 2018 | 1607 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2427 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4040 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2009 | 107 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2010 | 394 | 0.020 |
Why?
|
Prolactinoma | 1 | 2009 | 113 | 0.020 |
Why?
|
Face | 1 | 2014 | 1031 | 0.020 |
Why?
|
Nerve Net | 1 | 2020 | 2362 | 0.020 |
Why?
|
Corpus Striatum | 1 | 2014 | 1238 | 0.020 |
Why?
|
Poverty Areas | 1 | 2009 | 265 | 0.020 |
Why?
|
Massachusetts | 2 | 2012 | 8905 | 0.020 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2010 | 554 | 0.020 |
Why?
|
Hippocampus | 1 | 2020 | 3783 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4266 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10784 | 0.020 |
Why?
|
Prolactin | 1 | 2009 | 626 | 0.020 |
Why?
|
Collagen Type I | 1 | 2010 | 620 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2772 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2009 | 59679 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10358 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23839 | 0.020 |
Why?
|
Drug Utilization | 1 | 2012 | 1192 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2012 | 2005 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1514 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 42620 | 0.010 |
Why?
|
Learning | 1 | 2014 | 1762 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2014 | 2251 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 9066 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 6217 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1677 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9687 | 0.010 |
Why?
|
United States | 2 | 2021 | 73120 | 0.010 |
Why?
|
Self Concept | 1 | 2007 | 1050 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2047 | 0.010 |
Why?
|
Evoked Potentials, Auditory | 1 | 1984 | 533 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20232 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2012 | 2913 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41782 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2012 | 3077 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1984 | 866 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1984 | 1427 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 5043 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 30031 | 0.010 |
Why?
|
Nigeria | 1 | 1978 | 777 | 0.010 |
Why?
|
Hip Dislocation | 1 | 1978 | 249 | 0.010 |
Why?
|
Arthritis, Infectious | 1 | 1978 | 347 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14483 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15459 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13709 | 0.000 |
Why?
|
Aged | 2 | 2009 | 171514 | 0.000 |
Why?
|
Mice | 1 | 2008 | 82051 | 0.000 |
Why?
|